- HWN....browse for free, get verified to super communicate!
- HWN....No.1 E-platform for Healthcare professionals and the public!
- HWN....uniting and empowering healthcare professionals and the entire populace
- ..in a unique and systematic manner, through networking, couching and funding!
- HWN....empowering healthcare professionals and the entire populace!
- HWN....enlightening the general populace on health issues!
HWN Jobs
- IMO HEALTH SYSTEMS (IHS) JOBS
- WRS JOBS
- DAY WATERMAN COLLEGE (DWC) JOBS
- SENIOR TECHNICAL OFFICER MONITORING AND EVALUATION JOBS AT FAMILY HEALTH INTERNA
- JHPIEGO (DECEMBER) JOBS
HWN Blogs
- Classical heart healthy foods on HWN BLOGS
- Classical Warning Signs When The Human Liver Begins To Fail on HWN BLOGS
- Myths About Hygiene, Soaps, Germs, Sweat and Smell on HWN BLOGS
- Hernia does not heal on its own on HWN BLOGS
- Classical Essential Oils That Improves Focus Cum Memory on HWN BLOGS
news - Reduce risk of ESKD by intensive glucose control on HWN INSIGHTS back to all News
Reduce risk of ESKD by intensive glucose control on HWN INSIGHTS
For patients with type 2 diabetes, intensive glucose control has long-term benefits for preventing end-stage kidney disease (ESKD), according to a study published online March 22 in Diabetes Care.
Muh Geot Wong, M.D., Ph.D., from the University of Sydney, and colleagues examined the long-term effects of intensive glucose control on the risk of ESKD and other outcomes in survivors of the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Released Controlled Evaluation (ADVANCE) trial. A total of 8,494 ADVANCE participants, who had previously been randomized to intensive or standard glucose control, participated in a post-trial follow-up.
The researchers found that by the first post-trial visit, in-trial hemoglobin A1c differences disappeared. After 9.9 years of overall follow-up, the in-trial reduction in the risk of ESKD (seven versus 20 events; hazard ratio, 0.35; P = 0.02) persisted (29 versus 53 events; hazard ratio, 0.54; P < 0.01). Greater effects were seen in earlier-stage chronic kidney disease (P = 0.04) and at lower levels of baseline systolic blood pressure (P = 0.01). The glucose lowering effects on death, cardiovascular death, or major cardiovascular event risks did not vary according to levels of kidney function (P > 0.26).
Intensive glucose control was associated with a long-term reduction in ESKD, without evidence of any increased risk of cardiovascular events or death," the authors write. "These benefits were greater with preserved kidney function and with well-controlled blood pressure.
Several authors disclosed financial ties to the pharmaceutical industry; the ADVANCE trial and ADVANCE-ON follow-up study were partially funded by grants from Servier.
Source: MedExpress, HWN Africa.
: 2016-03-31 01:25:02 | : 1410
HWN News
- First Polish infant to survive on extreme dialysis on HWN MEDICAL MIRACLES
- Drug resistant tuberculosis end game on HWN INSIGHTS
- Too many women opting for caesarean sections (CS) to give birth on HWN SEX EDU
- The intelligent, strong and fearless Nurse that conquered Ebola on HWN ARCHIVE
- Medhi Benatia, down with injury on HWN SPORTS